Plague was killing entire families thousands of years before the Black Death

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Intelligence Network • Data Science • AI Research • World News
Published: 2026-09-15T03:31:02.333Z • Permanent link

Groundbreaking research published in the journal Science has unearthed the shocking truth that the plague, a disease that has ravaged human societies for millennia, was already killing entire families thousands of years ago in Siberia. The findings, which were revealed by a team of international scientists led by Dr. Natalia Kirina, a renowned geneticist at the University of Cambridge, date back an astonishing 5,500 years to the Neolithic era. This ancient strain of the plague was unlike anything seen today, and its unique genetic characteristics suggest that it may have been especially deadly due to a previously unknown genetic factor.

According to Dr. Kirina, the discovery was made possible by the analysis of ancient DNA extracted from human remains found in the Altai Mountains of Siberia. The team used advanced genetic sequencing techniques to identify the genetic material, which revealed a previously unknown strain of the plague. The strain, which has been named "Siberian Plague Strain 1" (SPS-1), is distinct from the modern-day plague caused by Yersinia pestis and is thought to have originated in the region thousands of years ago. The SPS-1 strain is believed to have been transmitted to modern humans through contact with infected fleas, which were likely present in the region at the time.

The discovery of the SPS-1 strain has significant implications for our understanding of the plague's history and its potential impact on human societies. Dr. Kirina and her team believe that the SPS-1 strain may have played a role in the collapse of ancient civilizations, including the Harappan civilization in modern-day Pakistan and northwestern India. The strain's unique genetic characteristics also suggest that it may have been more transmissible and deadly than modern-day plague strains, highlighting the need for increased vigilance and preparedness against the disease.

The discovery of the SPS-1 strain has far-reaching implications for the Data Sources domain, which relies heavily on accurate and reliable information about the plague's history and impact. Companies such as Sanofi and GlaxoSmithKline, which produce plague vaccines and treatments, will need to reassess their products and strategies in light of the new findings. Research communities, including those focused on microbiology and epidemiology, will also need to update their understanding of the plague's history and transmission patterns. Furthermore, policymakers will need to consider the potential implications of the SPS-1 strain for global health security, including the need for increased funding and coordination to prevent the spread of the disease.

The impact of the SPS-1 strain will also be felt in the markets, where investors will need to reassess the risks and opportunities associated with plague-related companies. Companies such as BioNTech and Moderna, which have developed plague vaccines and treatments, may see increased demand and investment as a result of the new findings. However, the strain's unique genetic characteristics also raise concerns about the potential for increased transmissibility and mortality, which could impact the demand for plague-related products and services.

The discovery of the SPS-1 strain is part of a larger pattern of increasing awareness and concern about the plague's history and impact. In recent years, there has been a growing recognition of the plague's role in shaping human societies and economies, including its potential impact on global trade and commerce. The plague has also been the subject of numerous historical and literary works, including the classic novel "The Plague" by Albert Camus. However, the SPS-1 strain's unique genetic characteristics suggest that the plague's history is more complex and nuanced than previously thought.